CDX-LIPO activates tumor-infiltrating macrophages and dendritic cells, promotes M1-polarization leading to antitumor immunity and tumor regression. CDX-LIPO promotes mTOR-mediated reprogramming of glucose metabolism in gliomas. Here, HMGA2 is linked to glioma.